FIELD: medicine; pharmacology.
SUBSTANCE: invention refers to pharmacology, namely to use of dimer dipeptide GSB-214 (heptamethylene diamide bis-(N-monosuccinyl-L-methionyl-L-serine)) as an agent possessing antidiabetic activity and relieving manifestations of depression accompanying diabetes.
EFFECT: invention extends the range of antidiabetic agents slowing the development of type 2 diabetes and exhibiting no hypoglycemic effect, and having antidepressant activity.
1 cl, 2 dwg, 3 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION BASED ON BIS-(N-MONOSUCCINYL-L-SERYL-L-LYSINE) HEXAMETHYLENEDIAMIDE (GSB-106) | 2018 |
|
RU2697254C1 |
| DRUG FOR PREVENTION AND TREATMENT OF DIABETES | 2013 |
|
RU2597848C2 |
| DIMERIC DIPEPTIDE MIMETIC BDNF AS AGENT FOR TREATING AND PREVENTING OPIOID ADDICTION | 2023 |
|
RU2823374C1 |
| DIMERIC DIPEPTIDE MIMETICS OF NEUROTROFIN-3 | 2022 |
|
RU2800369C1 |
| LOW-MOLECULAR MIMETIC BDNF AS AN AGENT FOR TREATING OPIOID DEPENDENCE | 2019 |
|
RU2707301C1 |
| SMALL MOLECULES WITH NGF-LIKE ACTIVITY AND ANTIDIABETIC PROPERTIES | 2013 |
|
RU2613314C2 |
| MEDICATION FOR PREVENTION AND CORRECTION OF DIABETES MANIFESTATIONS | 2012 |
|
RU2563234C2 |
| METHOD OF CORRECTING DEPRESSIVE DISORDERS BY THIETAN-1,1-DIOXIDE DERIVATIVES IN EXPERIMENT | 2010 |
|
RU2424799C1 |
| USE OF N,N"-SUBSTITUTED 3,7-DIAZABICYCLO[3_3_1]NONANES DERIVATIVES FOR DEPRESSION THERAPY | 2019 |
|
RU2726313C1 |
| 3,6,9-TRIAZATRICYCLOTETRADECANE DERIVATIVE AND USE THEREOF FOR TREATING DEPRESSION | 2019 |
|
RU2700595C1 |
